Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials

Схожие документы

• Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial
  по: Bhandari, Sunil, et al.
  Опубликовано: (2020)
• A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON‐EXT trial
  по: Achebe, Maureen M., et al.
  Опубликовано: (2020)
• A prospective, multi‐center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON‐IDA trial
  по: Auerbach, Michael, et al.
  Опубликовано: (2019)
• Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
  по: Auerbach, Michael, et al.
  Опубликовано: (2021)
• A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia
  по: Derman, Richard, et al.
  Опубликовано: (2017)